How ‘Going Under’ is Getting Greener
UCSF doctors are leading a national movement to protect patients and the environment from anesthesia-related pollution.
University of California San Francisco
Give to UCSFUCSF doctors are leading a national movement to protect patients and the environment from anesthesia-related pollution.
Ten UCSF graduate students presented their research in accessible, 3-minute talks at the 2024 Grad Slam event. This year’s first-place talk was by Ilina Bhaya-Grossman on how our brains make meaning out of groups of vowels, consonants and pauses in our native tongues to recognize words.
Carol Dawson-Rose, PhD, RN, FAAN, is named the new dean of the UCSF School of Nursing and associate vice chancellor for Nursing Affairs.
The Allen Institute is the newest member of the Weill Neurohub, a collaborative research network advancing treatments for neurological diseases.
Artificial intelligence could potentially help extract liver tumor data at a much faster and accurate rate, setting possibilities for improved liver cancer care.
Join Kelechi Okpara as she navigates through her whirlwind first day as a new medical resident at the UCSF Parnassus campus.
UCSF scientists found a way to predict Alzheimer’s disease up to seven years before symptoms appear by analyzing patient records with machine learning. Conditions that most influenced prediction of Alzheimer’s were high cholesterol and, for women, osteoporosis.
UCSF is a leading recipient of National Institutes of Health (NIH) funding for research, with a focus on advancing health sciences and medicine.
California’s trailblazing surgeon general is using her platform to pave the way for improving the health of women, children and communities of color while inspiring a new generation of Latinx physicians.
The two-year HEAL fellowship initiative operates in 10 countries but has a special focus on serving the Navajo Nation, which continues to suffer from the consequences of colonialism, including poor access to health care.
In a first, scientists at UCSF and Stanford identified genetic variants that predict whether a patient is likely to respond to treatment for preterm birth. Screening for mutations could allow doctors to target medications to those most likely to benefit. No medication is currently available in the U.S. to treat preterm birth.